• Something wrong with this record ?

Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma

L. Lenfant, A. Breda, E. Xylinas, M. Babjuk, M. Moschini, M. Rouprêt, EAU Section of Oncological Urology (ESOU) Board

. 2022 ; 5 (4) : 464-471. [pub] 20210922

Language English Country Netherlands

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22025020

This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion fashion, we will discuss the diagnostic and treatment options with two different perspectives: (1) guidelines-based current standard of care and (2) an outlook on future perspectives using the latest scientific advances that may soon become the standard of care. PATIENT SUMMARY: This presentation of a real-life clinical scenario will be useful in describing the current standard of care and future perspectives regarding the diagnosis and treatment of upper urinary tract tumors.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025020
003      
CZ-PrNML
005      
20221031100429.0
007      
ta
008      
221017s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.euo.2021.09.002 $2 doi
035    __
$a (PubMed)34561205
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Lenfant, Louis $u Urology, GRC n°5, Predictive Onco-Urology, AP-HP, Hôpital Pitié-Salpêtrière, Sorbonne University, Paris, France
245    10
$a Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma / $c L. Lenfant, A. Breda, E. Xylinas, M. Babjuk, M. Moschini, M. Rouprêt, EAU Section of Oncological Urology (ESOU) Board
520    9_
$a This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion fashion, we will discuss the diagnostic and treatment options with two different perspectives: (1) guidelines-based current standard of care and (2) an outlook on future perspectives using the latest scientific advances that may soon become the standard of care. PATIENT SUMMARY: This presentation of a real-life clinical scenario will be useful in describing the current standard of care and future perspectives regarding the diagnosis and treatment of upper urinary tract tumors.
650    12
$a karcinom z přechodných buněk $x diagnóza $x patologie $x terapie $7 D002295
650    _2
$a cystoskopie $7 D003558
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a ureter $x patologie $7 D014513
650    12
$a nádory močového měchýře $7 D001749
650    12
$a urologické nádory $x diagnóza $x terapie $7 D014571
655    _2
$a časopisecké články $7 D016428
700    1_
$a Breda, Alberto $u Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Barcelona, Spain
700    1_
$a Xylinas, Evangelos $u Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France
700    1_
$a Babjuk, Marek $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Second Faculty of Medicine and Hospital Motol, Charles University, Prague, Czech Republic
700    1_
$a Moschini, Marco $u Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland
700    1_
$a Rouprêt, Morgan $u Urology, GRC n°5, Predictive Onco-Urology, AP-HP, Hôpital Pitié-Salpêtrière, Sorbonne University, Paris, France. Electronic address: morgan.roupret@aphp.fr
710    2_
$a EAU Section of Oncological Urology (ESOU) Board
773    0_
$w MED00205913 $t European urology oncology $x 2588-9311 $g Roč. 5, č. 4 (2022), s. 464-471
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34561205 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100427 $b ABA008
999    __
$a ok $b bmc $g 1854629 $s 1176310
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 5 $c 4 $d 464-471 $e 20210922 $i 2588-9311 $m European urology oncology $n Eur Urol Oncol $x MED00205913
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options